This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Jiangxi Caishi Pharmaceutical Technology Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Libin Gan: Innovator in Pharmaceutical Crystallization
Introduction
Libin Gan is a notable inventor based in Suzhou, China. He has made significant contributions to the field of pharmaceutical technology, particularly in the development of novel crystal forms for therapeutic compounds. His work focuses on enhancing the efficacy and bioavailability of medications.
Latest Patents
Libin Gan holds a patent for a pyridone derivative crystal form and its preparation method. The patent details the crystals of a specific compound, which can be utilized for clinical treatment of influenza. The crystals, including various forms such as A, B, C, D, E, and F, demonstrate superior activity and bioavailability compared to existing pyridone derivatives. This innovation is particularly valuable as it can be used alone or in combination with other anti-influenza drugs, providing a promising solution for rapid clinical recovery.
Career Highlights
Libin Gan is associated with Jiangxi Caishi Pharmaceutical Technology Co., Ltd., where he applies his expertise in pharmaceutical research and development. His work has led to advancements in the stability, hygroscopicity, and storability of pharmaceutical crystals, meeting stringent requirements for medical use.
Collaborations
He collaborates with colleagues Li Chen and Qing Shao, contributing to a dynamic research environment that fosters innovation in pharmaceutical technology.
Conclusion
Libin Gan's contributions to the field of pharmaceutical crystallization highlight his role as an influential inventor. His patented work on pyridone derivatives showcases the potential for improved treatments in clinical settings.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile